Hep C Knowledge Bank

Bota S. et al. (2013) Role of interleukin-28B polymorphism as a predictor of sustained virological response in patients with chronic hepatitis C treated with triple therapy: a systematic review and meta-analysis. Clinical Drug Investigation, 33(5):325-331

Salk A. et al. (2013) Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature. Annals of Pharmaco

Romero-Gomez M. et al. (2013) Meta-analysis: pegylated interferon alpha-2a achieves higher early virological responses than alpha-2b in chronic hepatitis C. Alimentary Pharmacology & Therapeutics, 37(11):1065-1073.

Redulla R. et al. (2013) Adherence and completion in hepatitis C management: a systematic review. Gastroenterology Nursing, 36(1):53-58.

Rangnekar AS. et al. (2013) IL-28B polymorphisms and the response to antiviral therapy in HCV genotype 2 and 3 varies by ethnicity: a meta-analysis. Journal of Viral Hepatitis, 20(6):377-384.

Nair KC. et al. (2013) Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis. PLoS ONE, 8(2):e55364.

Moyer VA. (2013) U.S.Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 159(5):349-357.

Lieveld FI. et al. (2013) Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review. Annals of Hepatology, 12(3):380-391.

Kieran J. et al. (2013) The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1. Clinical Infectious Diseases, 56(2):228-235.

Huang TS. et al. (2013) A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma. Journal of Viral Hepatitis, 20(10):729-743.

Pages